Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidra Kalsoom

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Expert Review of Clinical Pharmacology|August 8, 2024
Sodium-glucose co-transporter 2 inhibition and acute myocardial infarction: the DAPA-MI and EMPACT-MI trialsMuhammad Adnan Zaman, Sidra Kalsoom
Future Cardiology|February 14, 2025
Reconsidering the role of beta-blockers in post-myocardial infarction patients with preserved ejection fractionSidra Kalsoom, Muhammad Adnan Zaman
Current Problems in Cardiology|January 17, 2024
Comment on "renal denervation for hypertension"Muhammad Hamza, Sidra Kalsoom, Asma Riaz
Expert Review of Clinical Pharmacology|July 15, 2024
CSL112 and HDL <i>function</i> hypothesis - a never-ending waitMuhammad Adnan Zaman, Sidra Kalsoom, Warsha Koran
JAMA Cardiology|May 21, 2025
Left Ventricular Noncompaction CardiomyopathyMuhammad Adnan Zaman, Sidra Kalsoom, Lou Mastrine
Cureus|August 5, 2024
Actinomyces neuii Causing Right-Sided Infective Endocarditis: A Case-Based Literature ReviewMuhammad A Zaman, Sidra Kalsoom, Latasha Naidu
Expert Review of Medical Devices|November 12, 2024
Modular cardiac rhythm management system and results of MODULAR ATP trial: an era of personalized device medicineMuhammad Adnan Zaman, Sidra Kalsoom, Lou Mastrine
Current Problems in Cardiology|March 2, 2024
Letter to editor: The relationship between vitamin D status and cardiovascular diseasesAsma Riaz, Sidra Kalsoom, Muhammad Hamza, et al.
Expert Review of Clinical Pharmacology|November 6, 2024
Role of tenecteplase in ischemic stroke after 4.5 hours: an evaluation of the TRACE-III trialMuhammad Imtiaz, Muhammad Adnan Zaman, Abeel Naseer, et al.
Expert Review of Clinical Pharmacology|October 29, 2024
Messenger interference RNA therapies targeting apolipoprotein C-III and angiopoietin-like protein 3 for mixed hyperlipidemia: the future of plozasiran and zodasiranZonghao Pan, Muhammad Adnan Zaman, Sidra Kalsoom, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Review of Clinical Pharmacology|August 8, 2024
Sodium-glucose co-transporter 2 inhibition and acute myocardial infarction: the DAPA-MI and EMPACT-MI trialsMuhammad Adnan Zaman, Sidra Kalsoom
Future Cardiology|February 14, 2025
Reconsidering the role of beta-blockers in post-myocardial infarction patients with preserved ejection fractionSidra Kalsoom, Muhammad Adnan Zaman
Current Problems in Cardiology|January 17, 2024
Comment on "renal denervation for hypertension"Muhammad Hamza, Sidra Kalsoom, Asma Riaz
Expert Review of Clinical Pharmacology|July 15, 2024
CSL112 and HDL <i>function</i> hypothesis - a never-ending waitMuhammad Adnan Zaman, Sidra Kalsoom, Warsha Koran
JAMA Cardiology|May 21, 2025
Left Ventricular Noncompaction CardiomyopathyMuhammad Adnan Zaman, Sidra Kalsoom, Lou Mastrine
Cureus|August 5, 2024
Actinomyces neuii Causing Right-Sided Infective Endocarditis: A Case-Based Literature ReviewMuhammad A Zaman, Sidra Kalsoom, Latasha Naidu
Expert Review of Medical Devices|November 12, 2024
Modular cardiac rhythm management system and results of MODULAR ATP trial: an era of personalized device medicineMuhammad Adnan Zaman, Sidra Kalsoom, Lou Mastrine
Current Problems in Cardiology|March 2, 2024
Letter to editor: The relationship between vitamin D status and cardiovascular diseasesAsma Riaz, Sidra Kalsoom, Muhammad Hamza, et al.
Expert Review of Clinical Pharmacology|November 6, 2024
Role of tenecteplase in ischemic stroke after 4.5 hours: an evaluation of the TRACE-III trialMuhammad Imtiaz, Muhammad Adnan Zaman, Abeel Naseer, et al.
Expert Review of Clinical Pharmacology|October 29, 2024
Messenger interference RNA therapies targeting apolipoprotein C-III and angiopoietin-like protein 3 for mixed hyperlipidemia: the future of plozasiran and zodasiranZonghao Pan, Muhammad Adnan Zaman, Sidra Kalsoom, et al.
Pageof 2